NICE-话题@MedSci

#NICE#

226篇内容 | 5155人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1288940, encodeId=c6d0128894047, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE指南——共患疾病临床评估和管理（NG.56）发布, objectType=article, longId=78149, objectId=3f8be8149ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f8be8149ae, replyNumber=0, likeNumber=32, createdTime=2016-09-23, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f8be8149ae, moduleTitle=2016NICE指南——共患疾病临床评估和管理（NG.56）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f8be8149ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288939, encodeId=936a128893921, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE指南——学习障碍患者心理健康问题的预防，评估和管理（NG.54）发布, objectType=article, longId=78086, objectId=7a18e8086a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a18e8086a9, replyNumber=0, likeNumber=32, createdTime=2016-09-23, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a18e8086a9, moduleTitle=2016NICE指南——学习障碍患者心理健康问题的预防，评估和管理（NG.54）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a18e8086a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288938, encodeId=49a012889388a, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=JAMA：疑似CHD的患者根据CMR指导护理1年内不必要的血管造影率较NICE指南的指导护理低, objectType=article, longId=76170, objectId=0eace617046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0eace617046, replyNumber=0, likeNumber=71, createdTime=2016-08-31, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0eace617046, moduleTitle=JAMA：疑似CHD的患者根据CMR指导护理1年内不必要的血管造影率较NICE指南的指导护理低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eace617046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288937, encodeId=21b7128893e92, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=大冢及施维雅结直肠癌复方新药Lonsurf英国NICE批准, objectType=article, longId=75978, objectId=2011e597805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2011e597805, replyNumber=0, likeNumber=114, createdTime=2016-08-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2011e597805, moduleTitle=大冢及施维雅结直肠癌复方新药Lonsurf英国NICE批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2011e597805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288936, encodeId=3ba3128893681, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=喜讯！辉瑞口服靶向抗癌药Xalkori（克唑替尼）获英国NICE推荐，一线治疗ALK阳性肺癌, objectType=article, longId=75774, objectId=c8c4e5774d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8c4e5774d2, replyNumber=0, likeNumber=67, createdTime=2016-08-25, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8c4e5774d2, moduleTitle=喜讯！辉瑞口服靶向抗癌药Xalkori（克唑替尼）获英国NICE推荐，一线治疗ALK阳性肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8c4e5774d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288935, encodeId=e31212889356b, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE指南——管制药品安全使用和管理（NG.46）发布, objectType=article, longId=75744, objectId=57f3e574406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f3e574406, replyNumber=0, likeNumber=40, createdTime=2016-08-25, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f3e574406, moduleTitle=2016NICE指南——管制药品安全使用和管理（NG.46）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57f3e574406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288934, encodeId=b5af128893443, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=喜讯！安进溶瘤免疫疗法获英国NICE批准治疗晚期黑色素瘤, objectType=article, longId=75247, objectId=4cd3e52471b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cd3e52471b, replyNumber=0, likeNumber=72, createdTime=2016-08-18, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cd3e52471b, moduleTitle=喜讯！安进溶瘤免疫疗法获英国NICE批准治疗晚期黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cd3e52471b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288933, encodeId=69b81288933f4, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=PTC杜氏肌营养不良药物Translarna获NICE支持批准, objectType=article, longId=73922, objectId=09e8e392282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09e8e392282, replyNumber=0, likeNumber=82, createdTime=2016-07-29, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09e8e392282, moduleTitle=PTC杜氏肌营养不良药物Translarna获NICE支持批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09e8e392282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288932, encodeId=485d128893210, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE指南：非霍奇金淋巴瘤的诊断和管理（NG.52）发布, objectType=article, longId=73687, objectId=9181e368792, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9181e368792, replyNumber=0, likeNumber=89, createdTime=2016-07-27, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9181e368792, moduleTitle=2016NICE指南：非霍奇金淋巴瘤的诊断和管理（NG.52）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9181e368792)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288931, encodeId=17f412889315f, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=优时比TNF抑制剂Cimzia获英国NICE批准用于类风湿性关节炎, objectType=article, longId=73296, objectId=60f9e329641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f9e329641, replyNumber=0, likeNumber=53, createdTime=2016-07-22, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f9e329641, moduleTitle=优时比TNF抑制剂Cimzia获英国NICE批准用于类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60f9e329641)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288930, encodeId=00e512889309b, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=百时美再受挫！NICE拒绝Opdivo用于肾癌治疗, objectType=article, longId=72296, objectId=be64e229622, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be64e229622, replyNumber=0, likeNumber=85, createdTime=2016-07-09, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be64e229622, moduleTitle=百时美再受挫！NICE拒绝Opdivo用于肾癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be64e229622)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288929, encodeId=6d4e12889293c, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=喜讯！葛兰素史克新型狼疮药Benlysta获英国NICE批准, objectType=article, longId=71597, objectId=064ee159736, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=064ee159736, replyNumber=0, likeNumber=55, createdTime=2016-06-26, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=064ee159736, moduleTitle=喜讯！葛兰素史克新型狼疮药Benlysta获英国NICE批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=064ee159736)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288928, encodeId=a6c91288928f0, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=本周糖尿病重磅：强生降糖药INVOKAMET获FDA批准一线治疗2型糖尿病，英国NICE推荐3种SGLT-2降糖药, objectType=article, longId=69405, objectId=846b694053d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=846b694053d, replyNumber=0, likeNumber=96, createdTime=2016-05-30, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=846b694053d, moduleTitle=本周糖尿病重磅：强生降糖药INVOKAMET获FDA批准一线治疗2型糖尿病，英国NICE推荐3种SGLT-2降糖药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=846b694053d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288926, encodeId=30de12889268e, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=葛兰素史克红斑狼疮药物Benlysta获英国NICE批准, objectType=article, longId=68074, objectId=6359680e44f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6359680e44f, replyNumber=0, likeNumber=72, createdTime=2016-05-14, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6359680e44f, moduleTitle=葛兰素史克红斑狼疮药物Benlysta获英国NICE批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6359680e44f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288927, encodeId=26f9128892eea, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=PCSK9抑制剂终于挺进英国！赛诺菲/安进降胆固醇药物 Praluent/Repatha同获NICE支持, objectType=article, longId=68075, objectId=8d55680e57d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d55680e57d, replyNumber=0, likeNumber=59, createdTime=2016-05-14, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d55680e57d, moduleTitle=PCSK9抑制剂终于挺进英国！赛诺菲/安进降胆固醇药物 Praluent/Repatha同获NICE支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d55680e57d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288925, encodeId=e5301288925f8, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=英国NICE推荐修美乐（Humira）治疗化脓性汗腺炎, objectType=article, longId=67904, objectId=8d336e904f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d336e904f2, replyNumber=0, likeNumber=81, createdTime=2016-05-12, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d336e904f2, moduleTitle=英国NICE推荐修美乐（Humira）治疗化脓性汗腺炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d336e904f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288924, encodeId=ee0712889242e, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=前列腺癌药物Jevtana获英国NICE支持, objectType=article, longId=67204, objectId=2d816e20454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d816e20454, replyNumber=0, likeNumber=60, createdTime=2016-04-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d816e20454, moduleTitle=前列腺癌药物Jevtana获英国NICE支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d816e20454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288923, encodeId=60e112889235a, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=喜报！诺华心衰药Entresto获NICE积极推荐, objectType=article, longId=65629, objectId=4a2f6562942, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a2f6562942, replyNumber=0, likeNumber=52, createdTime=2016-03-29, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a2f6562942, moduleTitle=喜报！诺华心衰药Entresto获NICE积极推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a2f6562942)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288922, encodeId=029612889227e, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=Vertex制药囊性纤维变性药物Orkambi遭英国NICE拒绝, objectType=article, longId=65586, objectId=93976558697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93976558697, replyNumber=0, likeNumber=71, createdTime=2016-03-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93976558697, moduleTitle=Vertex制药囊性纤维变性药物Orkambi遭英国NICE拒绝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93976558697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288921, encodeId=6eb912889215e, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE发布新的运动神经元病评估和管理指南, objectType=article, longId=64092, objectId=12d46409214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12d46409214, replyNumber=0, likeNumber=74, createdTime=2016-03-05, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12d46409214, moduleTitle=NICE发布新的运动神经元病评估和管理指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12d46409214)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NICE

2020-05-29

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE指南——共患疾病临床评估和管理（NG.56）发布

2016-09-23

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE指南——学习障碍患者心理健康问题的预防，评估和管理（NG.54）发布

2016-09-23

fusion (审核中...)

前往app查看评论内容

#NICE#

JAMA：疑似CHD的患者根据CMR指导护理1年内不必要的血管造影率较NICE指南的指导护理低

2016-08-31

fusion (审核中...)

前往app查看评论内容

#NICE#

大冢及施维雅结直肠癌复方新药Lonsurf英国NICE批准

2016-08-28

fusion (审核中...)

前往app查看评论内容

#NICE#

喜讯！辉瑞口服靶向抗癌药Xalkori（克唑替尼）获英国NICE推荐，一线治疗ALK阳性肺癌

2016-08-25

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE指南——管制药品安全使用和管理（NG.46）发布

2016-08-25

fusion (审核中...)

前往app查看评论内容

#NICE#

喜讯！安进溶瘤免疫疗法获英国NICE批准治疗晚期黑色素瘤

2016-08-18

fusion (审核中...)

前往app查看评论内容

#NICE#

PTC杜氏肌营养不良药物Translarna获NICE支持批准

2016-07-29

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE指南：非霍奇金淋巴瘤的诊断和管理（NG.52）发布

2016-07-27

fusion (审核中...)

前往app查看评论内容

#NICE#

优时比TNF抑制剂Cimzia获英国NICE批准用于类风湿性关节炎

2016-07-22

fusion (审核中...)

前往app查看评论内容

#NICE#

百时美再受挫！NICE拒绝Opdivo用于肾癌治疗

2016-07-09

fusion (审核中...)

前往app查看评论内容

#NICE#

喜讯！葛兰素史克新型狼疮药Benlysta获英国NICE批准

2016-06-26

fusion (审核中...)

前往app查看评论内容

#NICE#

本周糖尿病重磅：强生降糖药INVOKAMET获FDA批准一线治疗2型糖尿病，英国NICE推荐3种SGLT-2降糖药

2016-05-30

fusion (审核中...)

前往app查看评论内容

#NICE#

葛兰素史克红斑狼疮药物Benlysta获英国NICE批准

2016-05-14

fusion (审核中...)

前往app查看评论内容

#NICE#

PCSK9抑制剂终于挺进英国！赛诺菲/安进降胆固醇药物 Praluent/Repatha同获NICE支持

2016-05-14

fusion (审核中...)

前往app查看评论内容

#NICE#

英国NICE推荐修美乐（Humira）治疗化脓性汗腺炎

2016-05-12

fusion (审核中...)

前往app查看评论内容

#NICE#

前列腺癌药物Jevtana获英国NICE支持

2016-04-28

fusion (审核中...)

前往app查看评论内容

#NICE#

喜报！诺华心衰药Entresto获NICE积极推荐

2016-03-29

fusion (审核中...)

前往app查看评论内容

#NICE#

Vertex制药囊性纤维变性药物Orkambi遭英国NICE拒绝

2016-03-28

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE发布新的运动神经元病评估和管理指南

2016-03-05

科室
- - 订阅+
  - 更多科室
工具
服务